Pages that link to "Item:Q3442979"
From MaRDI portal
The following pages link to Adaptive Two-Stage Designs for Single-Arm Phase IIA Cancer Clinical Trials (Q3442979):
Displaying 12 items.
- Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trials (Q1727847) (← links)
- Two-stage design for phase II oncology trials with relaxed futility stopping (Q1747566) (← links)
- Spatial two-stage designs for phase II clinical trials (Q2076120) (← links)
- Optimal adaptive two-stage designs for phase II cancer clinical trials (Q2858002) (← links)
- MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION (Q4512728) (← links)
- Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials (Q4649069) (← links)
- Stopping for efficacy in single-arm phase II clinical trials (Q5093024) (← links)
- Adaptive two-stage optimal designs for phase II clinical studies that allow early futility stopping (Q5227806) (← links)
- BILITE: a Bayesian randomized phase II design for immunotherapy by jointly modeling the longitudinal immune response and time-to-event efficacy (Q6617390) (← links)
- Bayesian enhancement two-stage design with error control for phase II clinical trials (Q6617391) (← links)
- A Bayesian hierarchical monitoring design for phase cancer clinical trials: incorporating information on response duration into monitoring rules (Q6627959) (← links)
- Bayesian phase II clinical trial design with noncompliance (Q6628481) (← links)
